Glial Fibrillary Acidic Protein as a Marker of Disease in Relapsing Multiple Sclerosis: Post Hoc Analysis of Phase 3 Ozanimod Trials

ABSTRACT:

SUBMITTER: Harris S 

PROVIDER: S-EPMC12134391 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature